(Q97046479)
Statements
MATCH Treatment Subprotocol S1: Phase II Study of Trametinib in Patients With Tumors With NF1 Mutations (English)
0 references
25 February 2016
0 references
7 June 2018
0 references
50
0 references
18 year
0 references